Oragenics Inc (OGEN)

Oragenics Inc (OGEN) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $1.9M; returns 1 day +2.9%, 1 week -4.1%, 1 year -67.4%.

Oragenics, Inc. (OGEN) is a clinical-stage biotechnology company primarily focused on developing therapies for neurological conditions, with its lead program centered on ONP-002, an intranasal formulation targeting concussion and traumatic brain injury (TBI). The company has shifted from prior oral health and probiotic products (sold off in recent years) to a pure-play neurology pipeline.

Groups OGEN belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Neuroscience
• Neurological Disorders
• CNS Disorders
• Life Sciences
• R&D

OGEN financial model: income statement, cash flow and balance sheet